Vertex Pharmaceuticals Inc. VRTX, +4.02% shares were halted, but up 3.7%, after the Boston Globe reported that the biotech received marketing approval for a cystic fibrosis treatment.
headquarters_location: Vertex Pharmaceuticals, Boston